Correlation Between Takeda Pharmaceutical and STOMO MITSUI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and STOMO MITSUI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and STOMO MITSUI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical and STOMO MITSUI FINL, you can compare the effects of market volatilities on Takeda Pharmaceutical and STOMO MITSUI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of STOMO MITSUI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and STOMO MITSUI.

Diversification Opportunities for Takeda Pharmaceutical and STOMO MITSUI

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Takeda and STOMO is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical and STOMO MITSUI FINL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on STOMO MITSUI FINL and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical are associated (or correlated) with STOMO MITSUI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of STOMO MITSUI FINL has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and STOMO MITSUI go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and STOMO MITSUI

Assuming the 90 days trading horizon Takeda Pharmaceutical is expected to under-perform the STOMO MITSUI. But the stock apears to be less risky and, when comparing its historical volatility, Takeda Pharmaceutical is 1.58 times less risky than STOMO MITSUI. The stock trades about -0.01 of its potential returns per unit of risk. The STOMO MITSUI FINL is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  1,219  in STOMO MITSUI FINL on September 19, 2024 and sell it today you would earn a total of  1,020  from holding STOMO MITSUI FINL or generate 83.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.21%
ValuesDaily Returns

Takeda Pharmaceutical  vs.  STOMO MITSUI FINL

 Performance 
       Timeline  
Takeda Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
STOMO MITSUI FINL 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in STOMO MITSUI FINL are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain technical and fundamental indicators, STOMO MITSUI unveiled solid returns over the last few months and may actually be approaching a breakup point.

Takeda Pharmaceutical and STOMO MITSUI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Takeda Pharmaceutical and STOMO MITSUI

The main advantage of trading using opposite Takeda Pharmaceutical and STOMO MITSUI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, STOMO MITSUI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in STOMO MITSUI will offset losses from the drop in STOMO MITSUI's long position.
The idea behind Takeda Pharmaceutical and STOMO MITSUI FINL pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments